Share on

Global Prosthetic Heart Valves Market Size, Share, Trends, Growth & COVID-19 Impact Analysis Report – Segmented By Product and Region - Industry Forecast (2023 to 2028)

Published: March, 2023
ID: 2491
Pages: 180
Formats: report pdf report excel report power bi report ppt

Global Prosthetic Heart Valves Market Size (2023 to 2028)

The global prosthetic heart valves market size is predicted to be worth USD 12.75 billion by 2028 from USD 6.95 billion in 2023, growing at a CAGR of 12.90% during the forecast period.

The heart plays a vital role in the proper functioning of the human body by controlling blood flow. There are four main types of valves in the heart: tricuspid, pulmonary, mitral, and aortic valves. A prosthetic heart valve is a device implanted in a patient suffering from valve failures in the heart or other heart diseases, which puts the patient at risk of heart failure. They are implanted both as a pre-emptive treatment and a reactive treatment. The valves in the heart are integral to the normal functioning of the human body. They are evolved to perform tasks such as controlling the unidirectional flow of blood through the valve structure. Artificial valves must be designed to perform these tasks and be accepted by the body after transplantation. Tissue valves are generally preferred over mechanical valves because the latter requires additional anticoagulant administration for the proper functioning of the valve. The requirement is lifelong, whereas the tissue valve has no such needed further treatment.


The rising geriatric population, an increase in the prevalence of cardiac disorders such as rheumatic heart diseases, and the change in lifestyle of the people are majorly driving the global prosthetic heart valves market growth.

Other significant contributors include technological advancements, increased patient awareness, demand for minimally invasive cardiovascular surgeries, and a rise in the number of medical centers providing heart surgery. The Administration on Aging (AoA) predicts that by 2060, individuals aged 65 and over will grow to 98 million. The increasing population and the consequent rise in VHD prevalence are expected to drive the prosthetic heart valve demand growth in the United States. Besides, increased spending on healthcare will also allow the sector to expand. The Centre for Medicare & Medicaid Services (CMS) projects health spending in the U.S. to grow at an average rate of 5.5% per year, eventually reaching nearly US$ 6.0 trillion by 2027. Factors like advanced technologies for introducing new creative products, increasing demand for minimum tend to spread very quick surgeries, rise in the incidence of heart valve disorders, and creating opportunities for the global prosthetic heart valves market growth. The surge in massive collaborations and developments, an increase in several collaborations and partnerships, and the launch of products are some of the worldwide market trends.

The significant opportunity for growth in the global prosthetic heart valves market is transcatheter heart valves for new signs or indications. The survival rate is high for valve replacement among older adults suffering from valvular heart diseases, which leads to increasing demand for advanced prosthetic mitral valve implantation devices, which offers lucrative growth opportunities in the market.


Despite the numerous advantages, the prosthetic heart valve market remains in check by restraints such as the high costs of the valve and the treatment itself and the rigorous approval process for prosthetic valves before they are introduced into the global prosthetic heart valves market.

Impact of COVID-19 on the global prosthetic heart valves market:

The novel coronavirus (COVID-19) has caused significant changes in the healthcare landscape. With the introduction of the lockdown, the postponement of all elective cardiac surgeries was executed. The World Health Organization (WHO) declared the world as a pandemic emergency public health issue. Doctors working as frontline warriors in combat with COVID-19 also implement emergency and critical surgeries, saving patient lives. Moreover, COVID-19 patients with prosthetic heart valves will be at higher risk of bioprosthetic valve thrombosis. The demand for cardiovascular devices has decreased due to the reduction in the number of cardiac surgeries. Heart patients need to be very careful about getting infected with the virus. The patients should consult their cardiologists regarding concerns about the treatment for heart valve diseases. Patients with existing cardiac diseases are more susceptible to COVID-19. As there is no permanent cure for the infection, heart patients must be more careful without being infected and exposed to the coronavirus (COVID-19). Once the lockdown had uplifted, there is an increase in cardiac surgeries, and patients started visiting the hospitals. By the end of 2020 and 2021, the heart valve market will see an increase in growth rate. 




Market Size Available

2022 to 2028

Base Year


Forecast Period

2023 to 2028

Segments Analysed

By Product and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa


This research report has been segmented and sub-segmented the global prosthetic heart valves market based on the product and region.

Prosthetic Heart Valves Market - By Product:

  • Mechanical Heart Valve
  • Tissue Heart Valve
  • Stented Tissue Heart Valve
  • Stentless Tissue Heart Valve
  • Transcatheter Heart Valve

Based on product type, the tissue heart valve segment is the fastest-growing segment in the global market. But the Transcatheter Heart Valve segment accounts for the highest share due to an increase in older people and the incidence of aortic stenosis, new device approvals, and an increase in adoption rate for Transcatheter heart valve implantation procedure leads to the growth of the segmental growth.

Prosthetic Heart Valves Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, the global prosthetic heart valves market was dominated by North America in 2022, with the region accounting for over a third of the overall market share. In North America, the United States market is predicted to account largest market share during the forecast period. The U.S. healthcare system has been burdened majorly by valvular heart disease (VHD). Approximately 5 million people are diagnosed annually, according to the American College of Cardiology. The number of aortic stenosis sufferers is 1.5 million worldwide, with almost 500,000 individuals suffering from severe aortic stenosis. Due to calcium build-ups and scarring of the valve cusp due to age, VHD primarily affects the elderly population. North America was followed next in line by Europe and Asia-Pacific. The north American region is dominant in the global prosthetic heart valve market, accounting for a 41.8% share in value, followed by Europe. Due to well-developed healthcare infrastructure, technological advancements, rising healthcare expenditure, a growing number of heart surgeries, and increasing government funding in the region.

Asia-Pacific is expected to grow rapidly in the coming years, as evidenced by the high CAGR value for the region. Asia-Pacific is an emerging market that is projected to develop at a rapid rate. As a result of improving health infrastructure and the rising incidence of chronic disease in the region, predicting the growth in the prosthetic valves market in the Asia Pacific is realistic. Factors driving the growth of the prosthetic heart valve market in the area are also rising demographics and emerging economies.

The growth opportunities in existing countries like Latin America and the Middle East & Africa and transcatheter heart valves for new indications are regarded to provide numerous opportunities for the global prosthetic heart valves market growth during the foreseen period.


Some of the promising companies leading the Global Prosthetic Heart Valves Market profiled in this report are Corvia Medical, CardioKinetix, Biomerics LLC, Lepu Medical Technology, XELTIS BV, Comed BV, HLT, Meril Life Sciences, SYMETIS SA, and Transcatheter Technologies GmbH.

Medtronic developed self-extended percutaneous bioprosthetics, such as CoreValve Evolut R System and Medtronic CoreValve Evolut PRO System, each comprising an Aortic Valve Transcatheter (TAV), among other things. The TAV is an essential component; an artificial heart valve made of pig tissue made flexible and self-expanding by using Nickel and Titanium composite structure for support.

Please wait. . . . Your request is being processed


What is the current size of the global prosthetic heart valves market?

The global prosthetic heart valves market was valued at USD 6.16 billion in 2022. 

What are the factors driving the growth of the prosthetic heart valves market?

The growing prevalence of cardiovascular diseases, the aging population, technological advancements, and increasing awareness about heart valve diseases are propelling the growth of the prosthetic heart valves market.

Which regions are the largest markets for prosthetic heart valves?

North America and Europe are the largest markets for prosthetic heart valves due to the high prevalence of cardiovascular diseases in these regions.

What are the challenges facing the prosthetic heart valves market?

The high cost of the devices, the risk of complications associated with implantation, and the limited availability of skilled healthcare professionals are some of the key factors challenging the growth of the prosthetic heart valves market.

What are the key players in the prosthetic heart valves market?

Edwards Lifesciences Corporation, Medtronic, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, CryoLife, and JenaValve Technology are some of the key market players in the prosthetic heart valves market. 

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample